ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Feilong Zhou
Matched on ORCID iD 0009-0003-3347-8529; OpenAlex author ID A5037737884. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2024: 1 paper · 2025: 2 papers
Papers 3
- Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.omton.2025.201021↗
- Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013175↗
- An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2024.149931↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Youjia Cao · 3 shared papers, 2024–2025 · strength 0.60
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Paper Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancrea… DOI 10.1136/jitc-2025-013175↗
- Jiliang Zhao · 2 shared papers, 2024–2025 · strength 0.41
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Cuizhu Zhang · 2 shared papers, 2024–2025 · strength 0.41
- Paper Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic can… DOI 10.1016/j.omton.2025.201021↗
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Hongkai Zhang · 2 shared papers, 2024–2025 · strength 0.38
- Paper An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine p… DOI 10.1016/j.bbrc.2024.149931↗
- Paper Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancrea… DOI 10.1136/jitc-2025-013175↗
- Fan Li · 1 shared paper, 2025 · strength 0.19
- Jie Wang · 1 shared paper, 2025 · strength 0.19
- Shiyu Liu · 1 shared paper, 2025 · strength 0.19
- Yuanke Li · 1 shared paper, 2025 · strength 0.19
- Zhaoyuan Zhang · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.